Armata Pharmaceuticals Q4 EPS $(3.43) Misses $(0.28) Estimate, Sales $1.085M Beat $750.000K Estimate

Armata Pharmaceuticals (AMEX: ARMP) reported Q4 losses of $(3.43) per share, missing the analyst estimate of $(0.28) by 1125%. This represents a significant increase in losses compared to $(0.23) per share from the same period last year. However, the company achieved quarterly sales of $1.085 million, surpassing the $750,000 estimate by 44.67%, despite a 12.15% decline from $1.235 million in the previous year.